IDEAS home Printed from https://ideas.repec.org/a/plo/pntd00/0007482.html
   My bibliography  Save this article

Model-based assessment of public health impact and cost-effectiveness of dengue vaccination following screening for prior exposure

Author

Listed:
  • Guido España
  • Yutong Yao
  • Kathryn B Anderson
  • Meagan C Fitzpatrick
  • David L Smith
  • Amy C Morrison
  • Annelies Wilder-Smith
  • Thomas W Scott
  • T Alex Perkins

Abstract

The tetravalent dengue vaccine CYD-TDV (Dengvaxia) is the first licensed vaccine against dengue, but recent findings indicate an elevated risk of severe disease among vaccinees without prior dengue virus (DENV) exposure. The World Health Organization currently recommends CYD-TDV only for individuals with serological confirmation of past DENV exposure. Our objective was to evaluate the potential health impact and cost-effectiveness of vaccination following serological screening. To do so, we used an agent-based model to simulate DENV transmission with and without vaccination over a 10-year timeframe. Across a range of values for the proportion of vaccinees with prior DENV exposure, we projected the proportion of symptomatic and hospitalized cases averted as a function of the sensitivity and specificity of serological screening. Scenarios about the cost-effectiveness of screening and vaccination were chosen to be representative of Brazil and the Philippines. We found that public health impact depended primarily on sensitivity in high-transmission settings and on specificity in low-transmission settings. Cost-effectiveness could be achievable from the perspective of a public payer provided that sensitivity and the value of a disability-adjusted life-year were both high, but only in high-transmission settings. Requirements for reducing relative risk and achieving cost-effectiveness from an individual perspective were more restricted, due to the fact that those who test negative pay for screening but receive no benefit. Our results predict that cost-effectiveness could be achieved only in high-transmission areas of dengue-endemic countries with a relatively high per capita GDP, such as Panamá (13,680 USD), Brazil (8,649 USD), México (8,201 USD), or Thailand (5,807 USD). In conclusion, vaccination with CYD-TDV following serological screening could have a positive impact in some high-transmission settings, provided that screening is highly specific (to minimize individual harm), at least moderately sensitive (to maximize population benefit), and sufficiently inexpensive (depending on the setting).Author summary: Among several viral diseases transmitted by Aedes aegypti mosquitoes, dengue imposes the greatest and most persistent burden on global health. Efforts to curb its spread would benefit greatly from the availability of an effective vaccine. Currently, the only licensed dengue vaccine, known as CYD-TDV or by the brand name Dengvaxia, is only recommended for use in people who are known to have been exposed to dengue virus in the past. Because symptoms of dengue can range from severe to mild to imperceptible, using clinical history alone to assess whether a person was previously exposed is unreliable. Instead, serological assays, which measure a person’s immune response to dengue virus, are necessary to confirm whether a person was previously exposed. Because serological assays can be subject to substantial error, we used a simulation model to assess how impactful CYD-TDV vaccination would be under different scenarios about the accuracy of a serological assay and the intensity of transmission in a given area. We found that the health impact and cost-effectiveness of CYD-TDV vaccination depended on the accuracy of the serological assay, its cost, and the setting in which it is deployed.

Suggested Citation

  • Guido España & Yutong Yao & Kathryn B Anderson & Meagan C Fitzpatrick & David L Smith & Amy C Morrison & Annelies Wilder-Smith & Thomas W Scott & T Alex Perkins, 2019. "Model-based assessment of public health impact and cost-effectiveness of dengue vaccination following screening for prior exposure," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 13(7), pages 1-21, July.
    • Handle: RePEc:plo:pntd00:0007482
    DOI: 10.1371/journal.pntd.0007482
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0007482
    Download Restriction: no
    File URL: https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0007482&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pntd.0007482?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. A. Newall & M. Jit & R. Hutubessy, 2014. "Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines," PharmacoEconomics, Springer, vol. 32(6), pages 525-531, June.
    2. Alyssa Bilinski & Peter Neumann & Joshua Cohen & Teja Thorat & Katherine McDaniel & Joshua A Salomon, 2017. "When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs," PLOS Medicine, Public Library of Science, vol. 14(10), pages 1-10, October.
    3. Samir Bhatt & Peter W. Gething & Oliver J. Brady & Jane P. Messina & Andrew W. Farlow & Catherine L. Moyes & John M. Drake & John S. Brownstein & Anne G. Hoen & Osman Sankoh & Monica F. Myers & Dylan , 2013. "The global distribution and burden of dengue," Nature, Nature, vol. 496(7446), pages 504-507, April.
    4. A. Newall & M. Jit & R. Hutubessy, 2014. "Authors’ Reply to Gandjour: “Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines”," PharmacoEconomics, Springer, vol. 32(12), pages 1247-1247, December.
    5. Simon N. Wood & Natalya Pya & Benjamin Säfken, 2016. "Smoothing Parameter and Model Selection for General Smooth Models," Journal of the American Statistical Association, Taylor & Francis Journals, vol. 111(516), pages 1548-1563, October.
    6. Eunha Shim, 2017. "Cost-effectiveness of dengue vaccination in Yucatán, Mexico using a dynamic dengue transmission model," PLOS ONE, Public Library of Science, vol. 12(4), pages 1-17, April.
    7. Christopher Fitzpatrick & Alexander Haines & Mathieu Bangert & Andrew Farlow & Janet Hemingway & Raman Velayudhan, 2017. "An economic evaluation of vector control in the age of a dengue vaccine," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 11(8), pages 1-27, August.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Gerhart Knerer & Christine S M Currie & Sally C Brailsford, 2020. "The economic impact and cost-effectiveness of combined vector-control and dengue vaccination strategies in Thailand: results from a dynamic transmission model," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 14(10), pages 1-32, October.
    2. Jessica Ochalek & Karl Claxton & Paul Revill & Mark Sculpher & Alexandra Rollinger, 2016. "Supporting the development of an essential health package: principles and initial assessment for Malawi," Working Papers 136cherp, Centre for Health Economics, University of York.
    3. Jessica Ochalek & James Lomas & Karl Claxton, 2015. "Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data," Working Papers 122cherp, Centre for Health Economics, University of York.
    4. Georgios Gioldasis & Antonio Musolesi & Michel Simioni, 2020. "Model uncertainty, nonlinearities and out-of-sample comparison: evidence from international technology diffusion," Working Papers hal-02790523, HAL.
    5. Javad Moradpour & Aidan Hollis, 2021. "The economic theory of cost‐effectiveness thresholds in health: Domestic and international implications," Health Economics, John Wiley & Sons, Ltd., vol. 30(5), pages 1139-1151, May.
    6. Chris Desmond & Janet Seeley & Candice Groenewald & Nothando Ngwenya & Kate Rich & Tony Barnett, 2019. "Interpreting social determinants: Emergent properties and adolescent risk behaviour," PLOS ONE, Public Library of Science, vol. 14(12), pages 1-17, December.
    7. Sakirul Khan & Sheikh Mohammad Fazle Akbar & Takaaki Yahiro & Mamun Al Mahtab & Kazunori Kimitsuki & Takehiro Hashimoto & Akira Nishizono, 2022. "Dengue Infections during COVID-19 Period: Reflection of Reality or Elusive Data Due to Effect of Pandemic," IJERPH, MDPI, vol. 19(17), pages 1-12, August.
    8. Shengzhang Dong & George Dimopoulos, 2023. "Aedes aegypti Argonaute 2 controls arbovirus infection and host mortality," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    9. Zhao, Xinxing & Li, Kainan & Ang, Candice Ke En & Cheong, Kang Hao, 2023. "A deep learning based hybrid architecture for weekly dengue incidences forecasting," Chaos, Solitons & Fractals, Elsevier, vol. 168(C).
    10. Eunha Shim, 2017. "Cost-effectiveness of dengue vaccination in Yucatán, Mexico using a dynamic dengue transmission model," PLOS ONE, Public Library of Science, vol. 12(4), pages 1-17, April.
    11. Hone-Jay Chu & Bo-Cheng Lin & Ming-Run Yu & Ta-Chien Chan, 2016. "Minimizing Spatial Variability of Healthcare Spatial Accessibility—The Case of a Dengue Fever Outbreak," IJERPH, MDPI, vol. 13(12), pages 1-11, December.
    12. E. Zanini & E. Eastoe & M. J. Jones & D. Randell & P. Jonathan, 2020. "Flexible covariate representations for extremes," Environmetrics, John Wiley & Sons, Ltd., vol. 31(5), August.
    13. Cheng-Te Lin & Yu-Sheng Huang & Lu-Wen Liao & Chung-Te Ting, 2020. "Measuring Consumer Willingness to Pay to Reduce Health Risks of Contracting Dengue Fever," IJERPH, MDPI, vol. 17(5), pages 1-15, March.
    14. Amy R. Krystosik & Andrew Curtis & A. Desiree LaBeaud & Diana M. Dávalos & Robinson Pacheco & Paola Buritica & Álvaro A. Álvarez & Madhav P. Bhatta & Jorge Humberto Rojas Palacios & Mark A. James, 2018. "Neighborhood Violence Impacts Disease Control and Surveillance: Case Study of Cali, Colombia from 2014 to 2016," IJERPH, MDPI, vol. 15(10), pages 1-20, September.
    15. Laith Hussain-Alkhateeb & Tatiana Rivera Ramírez & Axel Kroeger & Ernesto Gozzer & Silvia Runge-Ranzinger, 2021. "Early warning systems (EWSs) for chikungunya, dengue, malaria, yellow fever, and Zika outbreaks: What is the evidence? A scoping review," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 15(9), pages 1-25, September.
    16. Jiang, Dong & Wang, Qian & Ding, Fangyu & Fu, Jingying & Hao, Mengmeng, 2019. "Potential marginal land resources of cassava worldwide: A data-driven analysis," Renewable and Sustainable Energy Reviews, Elsevier, vol. 104(C), pages 167-173.
    17. Benjamin Lopez-Jimena & Michaël Bekaert & Mohammed Bakheit & Sieghard Frischmann & Pranav Patel & Etienne Simon-Loriere & Louis Lambrechts & Veasna Duong & Philippe Dussart & Graham Harold & Cheikh Fa, 2018. "Development and validation of four one-step real-time RT-LAMP assays for specific detection of each dengue virus serotype," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 12(5), pages 1-22, May.
    18. Adriana Zubieta-Zavala & Guillermo Salinas-Escudero & Adrian Ramírez-Chávez & Luis García-Valladares & Malaquias López-Cervantes & Juan Guillermo López Yescas & Luis Durán-Arenas, 2016. "Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 10(8), pages 1-14, August.
    19. Fazli Wahid & Dr.Sajjad Ali & Jan Muhammad, 2021. "Effective Sources of Information in Winter Seasonal Diseases: The Perception of Residents of District Buner, KP," Journal of Media & Communication (JMC), Ilma University, Faculty of Media & Design, vol. 1(2), pages 215-229.
    20. Benjamin Säfken & Thomas Kneib, 2020. "Conditional covariance penalties for mixed models," Scandinavian Journal of Statistics, Danish Society for Theoretical Statistics;Finnish Statistical Society;Norwegian Statistical Association;Swedish Statistical Association, vol. 47(3), pages 990-1010, September.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pntd00:0007482. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosntds (email available below). General contact details of provider: https://journals.plos.org/plosntds/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.